Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE0657 in Obstructive Sleep Apnea
NCT00614250Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of AVE-0657 in obstructive sleep apnea (OSA), sponsored by Sanofi. Started Jan 2008; status: completed.
02
Drugs
AVE-0657
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT00614250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614250.